{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:25:36Z","timestamp":1726759536027},"reference-count":40,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T00:00:00Z","timestamp":1332288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Geriatrics Gerontology Int"],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:p><jats:bold>Aim:\u2003<\/jats:bold>To assess the preventive effect of atorvastatin on cardiovascular disease and on diabetes\u2010related events in elderly type\u20032 diabetic patients enrolled in the Japanese Elderly Diabetes Intervention Trial (J\u2010EDIT).<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold>Data were obtained from 1173 patients aged 65\u201384\u2003years who were enrolled in the J\u2010EDIT. Patients were followed prospectively for 6\u2003years to determine the effects of atorvastatin on serum cholesterol levels, and cardiovascular and diabetes\u2010related events. Because the study protocol allowed atorvastatin to be prescribed according to the clinical needs of each patient, we regarded the J\u2010EDIT data as if they came from a cohort study. We adjusted for clinical characteristics during the study as time\u2010dependent confounders using two methods, inverse\u2010probability\u2010of\u2010treatment (IPT) weighting and<jats:italic>g<\/jats:italic>\u2010estimation method.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold>The total follow\u2010up period was 5310.8\u2003person\u2010years (5.7\u2003years of median follow up), during which 202 patients received atorvastatin treatment. Atorvastatin was associated with moderate reductions in cholesterol levels: 24.2\u2003mg\/dL for total cholesterol, 22.9\u2003mg\/dL for low\u2010density lipoprotein (LDL) cholesterol and 24.3\u2003mg\/dL for non\u2010high\u2010density lipoprotein cholesterol at the first post\u2010treatment year. As a result, the proportion of patients who achieved targeted levels of LDL cholesterol clearly increased after atorvastatin treatment. Eight patients in 476.6\u2003person\u2010years among atorvastatin\u2010treated and 113 untreated patients in 4721.4\u2003person\u2010years had cardiovascular events (the composite end\u2010point of fatal\/non\u2010fatal myocardial infarction, angina pectoris, coronary intervention, and fatal\/non\u2010fatal cerebrovascular disease); hazard ratio (HR)\u2003=\u20030.48, 95% confidence interval (CI)\u2003=\u20030.19\u20131.16,<jats:italic>P<\/jats:italic>\u2003=\u20030.10, and HR\u2003=\u20030.32, 95% CI\u2003=\u20030.05\u20131.87,<jats:italic>P<\/jats:italic>\u2003=\u20030.21 from IPT weighting and<jats:italic>g<\/jats:italic>\u2010estimation method, respectively. Furthermore, seven in 475.0\u2003person\u2010years among atorvastatin\u2010treated and 149 untreated patients in 4682.4\u2003person\u2010years had diabetes\u2010related events (the composite end\u2010point of sudden death, renal failure death, death as a result of hyperglycemia or hypoglycemia, diabetic gangrene and congestive heart failure in addition to cardiovascular event); HR\u2003=\u20030.30, 95% CI\u2003=\u20030.12\u20130.77,<jats:italic>P<\/jats:italic>\u2003=\u20030.01, and HR\u2003=\u20030.40, 95% CI\u2003=\u20030.09\u20130.89,<jats:italic>P<\/jats:italic>\u2003=\u20030.03 from IPT weighting and<jats:italic>g<\/jats:italic>\u2010estimation method, respectively. When cardiovascular events were further differentiated into coronary vascular and cerebrovascular events, atorvastatin especially decreased the cerebrovascular risk.<\/jats:p><jats:p><jats:bold>Conclusion:\u2003<\/jats:bold>The use of atorvastatin to lower cholesterol levels in elderly Japanese patients with type\u20032 diabetes mellitus appears to reduce the risk of cardiovascular and diabetes\u2010related events.<jats:bold>Geriatr Gerontol Int 2012; 12 (Suppl. 1): 88\u2013102.<\/jats:bold><\/jats:p>","DOI":"10.1111\/j.1447-0594.2011.00816.x","type":"journal-article","created":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T20:18:53Z","timestamp":1332447533000},"page":"88-102","source":"Crossref","is-referenced-by-count":11,"title":["Effective prevention of cardiovascular disease and diabetes\u2010related events with atorvastatin in Japanese elderly patients with type\u20032 diabetes mellitus: Adjusting for treatment changes using a marginal structural proportional hazards model and a rank\u2010preserving structural failure time model"],"prefix":"10.1111","volume":"12","author":[{"given":"Tomohiro","family":"Shinozaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Iimuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Umegaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Japanese Elderly Diabetes Intervention Trial Research Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,3,21]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0195-668X(03)00347-6","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)","volume":"24","author":"De Backer G","year":"2003","journal-title":"Eur Heart J"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60104-X"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2376"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq165"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.5551\/jat.14.45"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16895-5"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13636-7"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021778"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.10.2713"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-09-0243"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-1-200707030-00002"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.5551\/jat1994.8.33"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0872"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199207000-00007"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1201\/9781420011579.ch23"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200009000-00011"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200009000-00012"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1198\/016214501753168154"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780121707"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009658"},{"key":"e_1_2_7_23_2","first-page":"4372","volume-title":"The Encyclopedia of Biostatistics","author":"Robins JM","year":"1998"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1064"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0594.2011.00808.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2007.02.004"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246970"},{"key":"e_1_2_7_28_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198524847.001.0001","volume-title":"Analysis of Longitudinal Data","author":"Diggle PJ","year":"2002"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1144"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780091214"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.860"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.047"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61965-6"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31818f69ce"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/1740774511402526"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2008.00673.x"},{"key":"e_1_2_7_37_2","unstructured":"ShinozakiT MatsuyamaY OhashiY.Estimating controlled direct effects for time\u2010varying treatments using structural nested mean models.2011. Joint Statistical Meetings Miami Beach FL July 30\u2010August 4 2011. Abstract 301065."},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31821d0507"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25219"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181bd5638"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn164"}],"container-title":["Geriatrics &amp; Gerontology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1447-0594.2011.00816.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1447-0594.2011.00816.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T21:19:21Z","timestamp":1713734361000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1447-0594.2011.00816.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,21]]},"references-count":40,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1111\/j.1447-0594.2011.00816.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1447-0594.2011.00816.x","archive":["Portico"],"relation":{},"ISSN":["1444-1586","1447-0594"],"issn-type":[{"type":"print","value":"1444-1586"},{"type":"electronic","value":"1447-0594"}],"subject":[],"published":{"date-parts":[[2012,3,21]]}}}